Meeting
2022 ASCO Genitourinary Cancers Symposium
Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management.
Authors
Hong Truong
Memorial Sloan Kettering Cancer Center, New York, NY
Hong Truong , Rania Sheikh , Yelena Kemel , Manuel De Jesus Escano , Aliya Khurram , Peter Reisz , Andrew Thomas Lenis , Alvin C. Goh , Eugene K. Cha , Bernard H. Bochner , Gopa Iyer , Jonathan E. Rosenberg , Dean F. Bajorin , David B. Solit , Zsofia Kinga Stadler , Alicia Latham , Kenneth Offit , Maria Isabel Carlo , Jonathan Coleman , Hikmat A. Al-Ahmadie
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 523)
DOI
10.1200/JCO.2022.40.6_suppl.523
Abstract #
523
Poster Bd #
G10
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
A prospective evaluation of universal tumor testing strategies for Lynch syndrome in endometrial cancer.
First Author: Kari Lassen Ring
Poster
2023 ASCO Annual Meeting
A pan-cancer statistical study of microsatellite instability and Lynch syndrome–associated mismatch repair genes germline mutations.
First Author: Huiya Cao
Poster
2023 ASCO Annual Meeting
Clinical and molecular characterization of microsatellite stable (MSS) tumors in patients with Lynch syndrome (LS).
First Author: Emily Harrold
Poster
2013 ASCO Quality Care Symposium
Implementing Lynch syndrome screening utilizing a community partnership.
First Author: Jennifer N. Eichmeyer